Literature DB >> 16203365

Pharmacological properties of ketamine.

J M White1, C F Ryan.   

Abstract

Ketamine is a dissociative anaesthetic that is being used in non-medical contexts. The effects of ketamine are very similar to those of phencyclidine, another dissociative anaesthetic that has enjoyed considerable popularity as a recreational drug. The effects of ketamine include analgesia, cardiovascular and respiratory stimulation, dissociation, hallucinations and anaesthesia. The potential dangers of uncontrolled ketamine use include psychosis and violence, accidents and marked psychomotor and cognitive impairment. Although studies have shown potential for tolerance to and physical dependence on ketamine, further investigation of these phenomena is needed. Ketamine is thought to produce most of its effects through antagonist activity at the PCP site of the NMDA receptor complex. Ketamine has sympathomimetic properties resulting from enhancement of catecholamine, and particularly dopamine, activity. While opioid receptor activity has been identified, this is relatively weak and the contribution to the effects of ketamine is not clear. Although much is known of the clinical uses and effects of ketamine, as yet little is understood of ketamine as a recreational drug and potential drug of dependence.

Entities:  

Year:  1996        PMID: 16203365     DOI: 10.1080/09595239600185801

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  22 in total

1.  Differences between adolescents and adults in the acute effects of PCP and ketamine and in sensitization following intermittent administration.

Authors:  Angelica Rocha; Nigel Hart; Keith A Trujillo
Journal:  Pharmacol Biochem Behav       Date:  2017-04-22       Impact factor: 3.533

2.  Mechanistic studies on ketamine-induced mitochondrial toxicity in zebrafish embryos.

Authors:  Bonnie L Robinson; Melanie Dumas; Syed F Ali; Merle G Paule; Qiang Gu; Jyotshna Kanungo
Journal:  Neurotoxicol Teratol       Date:  2017-12-07       Impact factor: 3.763

3.  Long-lasting effects of repeated ketamine administration in adult and adolescent rats.

Authors:  M L Shawn Bates; Keith A Trujillo
Journal:  Behav Brain Res       Date:  2019-04-26       Impact factor: 3.332

4.  General anesthesia for children with severe heart failure.

Authors:  Timothy W G Murphy; Jon H Smith; Michael R B Ranger; Simon R Haynes
Journal:  Pediatr Cardiol       Date:  2010-12-08       Impact factor: 1.655

5.  Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.

Authors:  James W Murrough; Dan V Iosifescu; Lee C Chang; Rayan K Al Jurdi; Charles E Green; Andrew M Perez; Syed Iqbal; Sarah Pillemer; Alexandra Foulkes; Asim Shah; Dennis S Charney; Sanjay J Mathew
Journal:  Am J Psychiatry       Date:  2013-10       Impact factor: 18.112

Review 6.  Ketamine : from medicine to misuse.

Authors:  Kim Wolff; Adam R Winstock
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

7.  Ceftriaxone reverses ketamine-induced lasting EEG and astrocyte alterations in juvenile mice.

Authors:  K Dodman; R E Featherstone; J Bang; Y Liang; S J Siegel
Journal:  Drug Alcohol Depend       Date:  2015-09-21       Impact factor: 4.492

8.  Effect of disulfiram on ketamine-induced cardiotoxicity in rats.

Authors:  Nihal Cetin; Bahadir Suleyman; Durdu Altuner; Ufuk Kuyrukluyildiz; Fatih Ozcicek; Resit Coskun; Nazahat Kurt; Halis Suleyman
Journal:  Int J Clin Exp Med       Date:  2015-08-15

9.  The role of ketamine in treatment-resistant depression: a systematic review.

Authors:  Gianluca Serafini; Robert H Howland; Fabiana Rovedi; Paolo Girardi; Mario Amore
Journal:  Curr Neuropharmacol       Date:  2014-09       Impact factor: 7.363

10.  The relation between the effect of a subhypnotic dose of thiopental on claw pain threshold in rats and adrenalin, noradrenalin and dopamine levels.

Authors:  Mehmet Aksoy; Ali Ahiskalioglu; Ilker Ince; Mine Celik; Aysenur Dostbil; Ufuk Kuyrukluyildiz; Durdu Altuner; Nezahat Kurt; Halis Suleyman
Journal:  Exp Anim       Date:  2015-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.